EP4337210A4 - Stabile pharmazeutische zusammensetzung mit selexipag - Google Patents

Stabile pharmazeutische zusammensetzung mit selexipag

Info

Publication number
EP4337210A4
EP4337210A4 EP22807969.5A EP22807969A EP4337210A4 EP 4337210 A4 EP4337210 A4 EP 4337210A4 EP 22807969 A EP22807969 A EP 22807969A EP 4337210 A4 EP4337210 A4 EP 4337210A4
Authority
EP
European Patent Office
Prior art keywords
selexipag
pharmaceutical composition
stable pharmaceutical
stable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22807969.5A
Other languages
English (en)
French (fr)
Other versions
EP4337210A2 (de
Inventor
Volkan ESKI
Srinivasa Reddy Almareddy
Udaya Kumar DUDE
Ravindra Patil
Ayush Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Original Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret AS filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Priority claimed from PCT/TR2022/050408 external-priority patent/WO2022240379A2/en
Publication of EP4337210A2 publication Critical patent/EP4337210A2/de
Publication of EP4337210A4 publication Critical patent/EP4337210A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
EP22807969.5A 2021-05-11 2022-05-10 Stabile pharmazeutische zusammensetzung mit selexipag Pending EP4337210A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202108066 2021-05-11
PCT/TR2022/050408 WO2022240379A2 (en) 2021-05-11 2022-05-10 A stable pharmaceutical composition comprising selexipag

Publications (2)

Publication Number Publication Date
EP4337210A2 EP4337210A2 (de) 2024-03-20
EP4337210A4 true EP4337210A4 (de) 2025-03-19

Family

ID=89898821

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22807969.5A Pending EP4337210A4 (de) 2021-05-11 2022-05-10 Stabile pharmazeutische zusammensetzung mit selexipag

Country Status (1)

Country Link
EP (1) EP4337210A4 (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3711763A1 (de) * 2017-11-16 2020-09-23 Nippon Shinyaku Co., Ltd. Formulierung mit kontrollierter freisetzung
US20210069187A1 (en) * 2019-05-11 2021-03-11 RK Pharma Solutions LLC Stable pharmaceutical composition of Selexipag
WO2021206159A1 (ja) * 2020-04-10 2021-10-14 日本新薬株式会社 固形製剤及びその製造方法
WO2023195955A1 (en) * 2022-04-05 2023-10-12 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A film coated tablet comprising selexi̇pag and its preparation process

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3711763A1 (de) * 2017-11-16 2020-09-23 Nippon Shinyaku Co., Ltd. Formulierung mit kontrollierter freisetzung
US20210069187A1 (en) * 2019-05-11 2021-03-11 RK Pharma Solutions LLC Stable pharmaceutical composition of Selexipag
WO2021206159A1 (ja) * 2020-04-10 2021-10-14 日本新薬株式会社 固形製剤及びその製造方法
WO2023195955A1 (en) * 2022-04-05 2023-10-12 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A film coated tablet comprising selexi̇pag and its preparation process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Uptravi - Assessment report", EMA/272184/2016, 1 April 2016 (2016-04-01), pages 1 - 117, XP055822500, Retrieved from the Internet <URL:https://www.ema.europa.eu/en/documents/assessment-report/uptravi-epar-public-assessment-report_en.pdf> [retrieved on 20210708] *

Also Published As

Publication number Publication date
EP4337210A2 (de) 2024-03-20

Similar Documents

Publication Publication Date Title
EP3914252A4 (de) Pharmazeutische zusammensetzung von nilotinib
EP3817722A4 (de) Pharmazeutische zusammensetzungen mit meloxicam
EP4003369A4 (de) Adenosinderivat und pharmazeutische zusammensetzung damit
MA47816A (fr) Composition pharmaceutique comprenant du sélexipag
EP3881846A4 (de) Pharmazeutische zusammensetzung mit parp-inhibitoren
MA51747A (fr) Formulation d&#39;anticorps pharmaceutique à ph faible
EP4132511A4 (de) Pharmazeutische zusammensetzungen mit meloxicam
MA46820A (fr) Composition pharmaceutique comprenant des constructions d&#39;anticorps bi-spécifiques
EP4122483A4 (de) Orale pharmazeutische zusammensetzung
EP4403573A4 (de) Pharmazeutische zusammensetzung mit bispezifischem anti-pvrig/tigit-antikörper
EP4023227A4 (de) Pharmazeutische zusammensetzung und verabreichung davon
EP4015001A4 (de) Orale pharmazeutische zusammensetzung
EP4456887A4 (de) Pharmazeutische zusammensetzung
MA45158A (fr) Composition pharmaceutique comprenant de l&#39;éteplirsen
EP3829576A4 (de) Pharmazeutische zusammensetzung mit eltrombopag olamin
EP3815688A4 (de) Pharmazeutische zusammensetzung mit schwerlöslicher basismedizin
EP3946296A4 (de) Pharmazeutische formulierung mit verlängerter freisetzung
EP3705122A4 (de) Medizinische zusammensetzung mit verzögerter freisetzung
EP3920909A4 (de) Pharmazeutische zusammensetzungen mit meloxicam
EP4176868A4 (de) Stabile pharmazeutische zusammensetzung
EP3753554A4 (de) Lacosamid enthaltende pharmazeutische zusammensetzung mit verzögerter freisetzung
EP4197540A4 (de) Arzneimittelformulierung mit sepetaprost
EP3881841A4 (de) Pharmazeutische zusammensetzung
EP3823659A4 (de) Pharmazeutische zusammensetzung mit einem polypeptid
EP3972578C0 (de) Ternäre pharmazeutische zusammensetzung enthaltend s1pr-modulatoren

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20231106

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RAV Requested validation state of the european patent: fee paid

Extension state: MA

Effective date: 20231106

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031496500

Ipc: A61K0009200000

A4 Supplementary search report drawn up and despatched

Effective date: 20250213

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/12 20060101ALI20250207BHEP

Ipc: A61K 31/4965 20060101ALI20250207BHEP

Ipc: A61K 9/20 20060101AFI20250207BHEP